Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective, less costly, or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.

Contact
The Investor Relations Group:
Erika Moran, Investor Relations
Janet Vasquez, Public Relations
(212) 825-3210

FINANCIAL TABLES FOLLOWGEOVAX LABS, INC.Condensed Consolidated Statements of Operations Information(amounts in thousands, except per share data)Three Months EndedMarch 31, 2012

2011RevenuesGrant Revenue$
854

$
893Operating expenses:Research and development1,072

838General and administrative513

6621,585

1,500Other income:Interest income1

11

1Net loss$
(730)

$
(606)Loss per common share$  (0.04)

$
(0.04) GEOVAX LABS, INC.Condensed Balance Sheet Information(amounts in thousands)March 31,

Dec. 31,2012

2011Assets:Cash and cash equivalents$
2,240

$
,168Other current assets393

250Total current assets2,633

1,418Property, net 158

176Other assets46

51Total assets$
2,837

$
,645Liabilities and stockholders' equityCurrent liabilities$
510

$
941Stockholders' equity2,327

704Total liabilities and stockho
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... Jan. 15, 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was promoted from ... has overseen the company,s four facilities in Massachusetts ... Mr. King joined Tegra Medical in 2012 with 20+ years ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
(Date:4/22/2014)... Jerusalem, April 22, 2014 -- In parallel with modern man ... of humans with whom we lived side by side, such ... Yet only Homo sapiens survived. What was it ... The truth is that little is known about our unique ... it contributed to the fact that we are the only ...
(Date:4/22/2014)... exposed to trauma, illness, alcohol or other drug abuse, ... brain cells that can go awry and activate conditions ... of autism. , Until now, it has been unclear ... a developing brain. Past studies have shown that when ... abuse or she experiences some trauma or illness, her ...
(Date:4/22/2014)... be influenced by low exposure to testosterone in the ... how men,s testosterone levels may be determined before they ... of the hormone than others is important because testosterone ... the hormone have been linked to obesity, diabetes and ... responsible for producing testosterone in adults known as ...
(Date:4/22/2014)... stroke intervention researchers have been informed that the National ... National Institutes of Health, will award an $8 million ... of an experimental drug for stroke. , The ... tissue plasminogen activator, or rtPA the "clot-busting" drug ... In laboratory rodent studies, 3K3A-APC, used in combination with ...
(Date:4/22/2014)... 22, 2014) Older parents are more likely to ... (ASD) than are younger parents. A recent study from ... in Philadelphia and Karolinska Institute in Sweden provides more ... varies between mothers, and fathers, ages, and found that ... and intellectual disability is larger for older parents., In ...
Breaking Medicine News(10 mins):Health News:What gave us the advantage over extinct types of humans? 2Health News:Life stressors trigger neurological disorders, researchers find 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:Child's autism risk accelerates with mother's age over 30 2Health News:Child's autism risk accelerates with mother's age over 30 3
... Sint Antonius Hospital in Nieuwegein, the Netherlands say that ... air and belch more frequently, air swallowing does not ... to test whether air swallowing had any role in ... esophagus of 12 people with GERD and 12 healthy ...
... new study says that drinking alcohol is linked to ... of drinking//. ,"Social drinking builds social capital," ... Jose State University. "Social drinkers are out networking, ... result in bigger paychecks." ,The researchers said that ...
... Rosiglitazone, an oral drug used to reduce the amount of sugar ... a study.// ,Type 2 diabetes occurs when people cannot ... is the essential hormone that helps sugars to be turned into ... regulate their use of glucose are at high risk of Type ...
... — the grocery store — can help improve and ... a new study conducted in the Marshall// Islands. By ... habits, the researchers were able to foster an increase ... ,“Diet-related chronic diseases are at epidemic proportions, ...
... already suffered a stroke could run a further risk of ... findings of a new study. Recurrent// strokes could also disable ... Ruland, of the University at Chicago said” Stroke incidence and ... whites. Part of this risk may be explained by a ...
... confirmed in Wisconsin, the outbreak of the disease is ... One person has succumbed to the disease in the ... of the 30 cases have needed hospital admission and ... the patients are women. ,The places ...
Cached Medicine News:Health News:‘Healthy Stores’ Program Boosts Demand for Better Food in Marshall Islan 2
Lorgnette pinhole occluder...
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Long handle occluders are approximately 9 inches long....
Medicine Products: